US FDA Food Safety Overhaul Will Have Ripple Effects For Drug Inspections
Executive Summary
A restructuring of FDA’s food safety operations includes changes to the agency-wide office that handles all inspections, including those of drug manufacturers. It’s another shift in the delicate balancing of centralized management of ORA with the specific needs and priorities of the different centers.
You may also be interested in...
Regulatory Affairs Head Should Be ‘Highly Technically Competent’ But ‘Splendid On Human Side' – FDA Commissioner Califf
Agency has seen ‘a good slate of applicants’ for the post of associate commissioner for regulatory affairs, who will oversee a revamped field organization focused on inspections, investigations and imports. New update to the reorg plans calls for medical product and specialty labs to be moved out of the Office of Regulatory Affairs and relocated to the Office of the Chief Scientist.
US FDA’s New Regulatory Affairs Head Should Be ‘Highly Technically Competent’ But ‘Splendid On The Human Side,’ Califf Says
Agency has seen ‘a good slate of applicants’ for the post of associate commissioner for regulatory affairs, who will oversee a revamped field organization focused on inspections, investigations and imports. New update to the reorg plans calls for medical product and specialty labs to be moved out of the Office of Regulatory Affairs and relocated to the Office of the Chief Scientist.
‘Stop Fighting' US FDA On Inspections As Food Safety Overhaul Brings ‘Big Change’ To Drug Systems – Califf
Commissioner Califf underscores need to keep inspections systems ‘tuned up’ to prevent manufacturers from ‘losing their edge’ on quality.